N-terminal nesprin-2 variants regulate β-catenin signalling by Zhang, Qiuping et al.
Experimental Cell Research 345 (2016) 168–179Contents lists available at ScienceDirectExperimental Cell Researchhttp://d
0014-48
Abbre
nuclear
dystrop
nucleos
croscop
vascular
umbilic
n Corr
James B
E-mjournal homepage: www.elsevier.com/locate/yexcrResearch ArticleN-terminal nesprin-2 variants regulate β-catenin signalling
Qiuping Zhang, Rose-Marie Minaisah, Elisa Ferraro, Chen Li, Lauren J. Porter, Can Zhou,
Fang Gao, Junyi Zhang, Dipen Rajgor, Flavia Autore, Catherine M. Shanahan,
Derek T. Warren n
British Heart Foundation Centre of Research Excellence, Cardiovascular Division, King's College, SE5 9NU London, UKa r t i c l e i n f o
Article history:
Received 19 October 2015
Received in revised form
13 June 2016
Accepted 14 June 2016
Available online 16 June 2016
Keywords:
Nesprin-2
Β-catenin
Cell-cell junctions
Scaffold proteinx.doi.org/10.1016/j.yexcr.2016.06.008
27/& 2016 The Authors. Published by Elsevie
viations: NE, nuclear envelope; ONM, outer nu
membrane; F-actin, ﬁlamentous actin; EDMD
hy; CHD, calponin homology domain; SR, spe
keleton and cytoskeleton; WB, Western blot;
y; IP, immunoprecipitation; ESC, embryonic s
smooth muscle cell; HDF, human dermal ﬁb
al vein endothelial cells
espondence to: Kings College London, Divisio
lack Centre, 125 Coldharbour Lane, London SE
ail address: derek.warren@kcl.ac.uk (D.T. Wara b s t r a c t
The spatial compartmentalisation of biochemical signalling pathways is essential for cell function. Ne-
sprins are a multi-isomeric family of proteins that have emerged as signalling scaffolds, herein, we in-
vestigate the localisation and function of novel nesprin-2 N-terminal variants. We show that these ne-
sprin-2 variants display cell speciﬁc distribution and reside in both the cytoplasm and nucleus. Im-
munoﬂuorescence microscopy revealed that nesprin-2 N-terminal variants colocalised with β-catenin at
cell-cell junctions in U2OS cells. Calcium switch assays demonstrated that nesprin-2 and β-catenin are
lost from cell-cell junctions in low calcium conditions whereas emerin localisation at the NE remained
unaltered, furthermore, an N-terminal fragment of nesprin-2 was sufﬁcient for cell-cell junction locali-
sation and interacted with β-catenin. Disruption of these N-terminal nesprin-2 variants, using siRNA
depletion resulted in loss of β-catenin from cell-cell junctions, nuclear accumulation of active β-catenin
and augmented β-catenin transcriptional activity. Importantly, we show that U2OS cells lack nesprin-2
giant, suggesting that the N-terminal nesprin-2 variants regulate β-catenin signalling independently of
the NE. Together, these data identify N-terminal nesprin-2 variants as novel regulators of β-catenin
signalling that tether β-catenin to cell-cell contacts to inhibit β-catenin transcriptional activity.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Nesprins are a family of spectrin repeat containing proteins
that are encoded by four genes (SYNE1-4) [1–4]. Nesprins-1 and -2
are highly complex and multiple variants arise due to alternative
initiation and termination of the genes [5]. The giant nesprin-1
and -2 variants consist of an N-terminal paired calponin homology
domain (CHD) that has been shown to bind ﬁlamentous actin (F-
actin), a central rod region composed of numerous spectrin re-
peats and a C-terminal Klarsicht, ANC-1, SYNE Homology (KASH)
domain that is required for the nuclear envelope (NE) localisation
of these proteins [4,6,7]. To date, the best studied function of these
proteins is at the NE, where smaller variants function to organise
the inner nuclear membrane (INM) via interactions with lamins A/r Inc. This is an open access article
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ren).C and emerin [6,8], whereas the nesprin giant variants reside on
the outer nuclear membrane (ONM) and are components of the
LInker of Nucleoskeleton to Cytoskeleton (LINC) complex. The LINC
complex physically couples the ONM to the INM via interactions
between the KASH domain of nesprins and the SUN domain of
SUN1/2 in the perinuclear space [9,10]. SUN1/2 span the INM and
interact with lamins A/C [11,12], thus forming a continuous bio-
physical network between the cytoskeleton and nucleoskeleton
[10–12]. In addition to the giant nesprin-1 and -2 isoforms, nesprin
variants that lack the KASH domain have been shown to localise to
the cytoplasm and nucleoplasm [5,13–15]. Although the functions
of these KASH-less variants remain to be fully deﬁned, they show
tissue and cell speciﬁc expression patterns, suggesting nesprins
are tailored for speciﬁc cellular functions.
Nesprins are comprised of multiple spectrin repeats that are
proposed to mediate protein-protein interactions, however, our
knowledge of nesprin binding partners remains limited [16]. At
the INM, nesprin variants interact with lamins A/C, SUN1/2 and
emerin [6,12]. Mutations in these nesprin variants result in emerin
mislocalisation, nuclear morphology defects and are associated
with Emery–Dreifuss muscular dystrophy (EDMD), suggesting that
nesprins perform a scaffolding role at the NE [1]. KASH-less var-
iants also perform a scaffolding role in the nuclear interior and we
have previously identiﬁed nesprin-2 as a nuclear ERK scaffold thatunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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regulate proliferation [14]. Importantly, several cytoplasmic bind-
ing partners have also been identiﬁed for nesprin-1 and -2 in-
cluding the RNA binding proteins Dcp1a, Rck and Ago2, and
meckelin, respectively [13,17]. Moreover, nesprin-1 and -2 KASH-
less variants localise to focal adhesions and actin/microtubule ﬁ-
laments, suggesting that the cytoplasmic KASH-less variants may
perform a similar scaffolding role [5,13]. Nesprin-2 has also been
implicated in the WNT pathway that transfers signals from the
plasma membrane to the nucleus via nuclear translocation of the
transcription factor β-catenin [18–21]. Both α- and β-catenin in-
teract with spectrin repeats (SRs) toward the C-terminus of ne-
sprin-2 giant to attenuate β-catenin signalling [22]. In addition to
this direct interaction, nesprin-2 may also indirectly associate with
β-catenin at the INM, where the nesprin-2 binding protein emerin
interacts with β-catenin to facilitate its nuclear export [23].
In this study we investigate the role of recently identiﬁed
N-terminal nesprin-2 variants that retain the CHD but lack the
KASH domain. We show that these variants are novel components
of cell-cell junctions, where they colocalise and interact with β-
catenin. Importantly, these nesprin-2 variants anchor β-catenin to
cell-cell junctions to negatively regulate β-catenin mediated
transcriptional activity.2. Materials and methods
2.1. Cell culture
Human bone osteosarcoma epithelial (U2OS), human umbilical
vein endothelial cells (HUVEC), mouse C2C12 myoblast, human
dermal ﬁbroblast and human vascular smooth muscle cells were
cultured as described previously [24,25]. The following nesprin-2
siRNA oligomers targeting the N-terminus of the giant variant
were used in this study: siN2CH2 (5′ AGGAAGACACCCAGAAGUU
3′), siN2CH3 (5′ CUUCAGAAUUGCAGAACAAUU 3′), siN2CH5 (5′
GCCUUCACGUGCUGGAUAAUU 3′), p220CHNesp2 3′UTR1 (5′ GA-
GAAUAGUCUGUGGAGAAUU 3′), p220CHNesp2 3′UTR2 (5′ GGAAC-
GUAGUGGAGGAUAUU 3′), p380CHNesp2 3′UTR1 (5′ AUCGAAAGC-
CAGAGAGUAAUU 3′) and p380CHNesp2 3′UTR2 (5′ AGUCAGAGGU-
CAACAACAAUU 3′) (Dharmacon). C-terminal nesprin-2 siRNA de-
signed to a region close to the KASH domain (siN2KASH) have
been described previously [14]. Emerin smart pool siRNA oligo-
mers from Dharmacon were used in this study. Transfection of
siRNA was performed using HiPerfect (Qiagen), as per manufac-
turer's instructions. DNA transfections of were performed with
Fugene (Promega) as per manufacturer's instructions.
2.2. PCR and 3′UTR ampliﬁcation
PCR for N-terminal nesprin-2 3′UTRs were performed using 3′
UTR speciﬁc primer sets as described previously [5].
2.3. Nesprin constructs
The following N-terminal nesprin-2 fragments were cloned
into pEGFP-C1 vector (Clontech): ABDN2 (amino acids 1-531). The
CHDN2 (amino acids 1-278) fragment was cloned into the pCMV-
Tag vector (Agilent Technologies). The SR 1-3 region (amino acids
279-531) was cloned into the pGEX4T-1 (Amersham) and pCMV-
Tag (Agilent Technologies) vectors.
2.4. Calcium switch assay
Cells were grown to 80–100% conﬂuency and serum starved
overnight. Next day, cells were incubated with 4 mM EGTA incalcium free media for 1 h to promote cadherin mediated cell-cell
junction disassembly. Junction re-assembly was promoted by in-
cubating cells in media containing 1.8 mM calcium for 1 h. Cells
were ﬁxed and processed for immunoﬂuorescence microscopy.
2.5. Western blot analysis, antibodies and immunoﬂuorescence
microscopy
Cell lysates were run on 5% or 8% polyacrylamide gels and
subjected to Western blotting as described previously [6]. Anti-
bodies used for Western blot, confocal immunoﬂuorescence mi-
croscopy (IF) and immunoprecipitation were; GFP (ab290), GFP-
Sepharose (ab69314) (Abcam), Vinculin (Sigma), Emerin (VP-E602)
(Vector Labs), lamin A/C (sc-6215) (Santa Cruz), total β-catenin,
active β-catenin clone 8E7 (05-665) (Millipore), nesprin-2 CH3
and nesprin-2 N3 (Immune Systems). N2CH3 peptide blocking
experiments were performed as described previously using the
peptide KRDLDELKDHLQL (Immune Systems) [6]. Filamentous ac-
tin was observed by IF using Rhodamine phalloidin (Invitrogen).
Secondary antibodies for WB were horseradish peroxidase-con-
jugated anti mouse (NA931) or anti rabbit (NA94V) antibodies
from GE Healthcare. ECL chemiluminescent kit (RPN2132, GE
Healthcare) was used for detection according to manufacturer's
instructions. Invitrogen anti-mouse Alexa ﬂuor 568 (A11031) and
anti-rabbit Alexa ﬂuor 488 (A11034) were used as IF secondary
antibodies. For IF cells were cultured on cover slips, ﬁxed in 4%
paraformaldehyde (Sigma), permeabilised in 0.5% NP-40 (Sigma)
and processed as described previously [6]. All images were cap-
tured at 63  magniﬁcations using a Leica SP5 laser scanning
confocal microscope.
2.6. Immunoprecipitation, GST pull-downs and subcellular
fractionations
Subcellular fractionations were performed as described pre-
viously [14]. GST expression, puriﬁcation and pull-down assays
were performed as described previously [14]. For im-
munoprecipitation (IP), U2OS cells were transfected with either
GFP or GFP-ABDN2 and incubated overnight. Cells were processed
for IP as described previously [14]. GFP was immunoprecipitated
by incubating with anti-GFP coated Sepharose beads for 2 h at
4 °C. Beads were washed three times in IP buffer before bound
proteins were eluted in sample buffer, as described previously [14].
Coomassie staining was performed using the Bio-Safe™ Coomassie
stain (BIORAD) as per manufacturer's instructions.
2.7. Luciferase assays
U2OS cells were seeded onto a 6 well plate at a density of
2.5105 cells per well. Next day cells were transfected with
mixtures of 1 mg TOP-FLASH or FOP-FLASH, 0.1 mg TK Renilla and
1 mg of GFP, GFP-ABDN2, FLAG or FLAG-SR 1-3 using Fugene
(Promega). Cells were incubated overnight. For analysis of siRNA
on transcriptional activity the TOP-FLASH or FOP-FLASH and TK
Renilla mix was added directly to siRNA transfection mixture
containing HiPerfect (Qiagen). Cells were incubated for 48 h. Lu-
ciferase and Renilla activities were assayed using the Dual-Glos
Luciferase assay system (Promega) as per manufacturer’s instruc-
tions. Control Luciferase activities were assigned a value of 1.
2.8. Statistical analysis
Results are presented as mean þ/ SEM. For comparison of
siRNA knockdown groups paired Student's t-tests or one way
ANOVA with Bonferroni's post-test were performed.
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3.1. Cell speciﬁc distribution of nesprin-2 variants
Recently, 3′UTRs encoding KASH-less N-terminal nesprin-2A.
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ﬁbroblast (HDF) and mouse C2C12 myoblast cells. The
p380CHNesp2 variant was abundant in U2OS, HDF and myoblast
cells, but lacking in human umbilical vein endothelial cells (HU-
VEC) and VSMCs (Fig. 1B). Western blot analysis (WB) was per-
formed on whole cell lysates using an antibody raised to the
N-terminus of the nesprin-2 giant (N2CH3) (Fig. 1C). To conﬁrm
the speciﬁcity of the N2CH3 antibody we performed peptide
blocking experiments and show that the activity of the antibody is
efﬁciently blocked by the target sequence on WB (Supplementary
Fig. 1A). In agreement with the PCR data, we show that U2OS cells
possess both the p220CHNesp2 and p380CHNesp2 variants whereas
VSMCs and HDFs possess either the p220CHNesp2 or p380CHNesp2
variant, respectively (Fig. 1D). Importantly, using the N2CH3 an-
tibody and a C-terminal nesprin-2 antibody (N2N3) we show that
the nesprin-2 giant is highly abundant in VSMCs but was not de-
tectable in U2OS and HDF cells tested (Fig. 1C and D). As previous
studies have shown that the nesprin-2 giant is present in HDF cells
at low levels, we performed subcellular fractionation experiments
to concentrate the nuclear proteins [26]. WB revealed that ne-
sprin-2 giant was weakly present in HDF nuclear fractions. Im-
portantly, nesprin-2 giant was not detected in U2OS nuclear
fractions, further conﬁrming that U2OS cells lack nesprin-2 giant
(Supplementary Fig. 1B).
Subcellular fractionation of U2OS cells demonstrated that
p220CHNesp2 and p380CHNesp2 reside in both the cytoplasmic and
nuclear fractions (Fig. 2A). In addition, smaller unknown nesprin-2
bands were observed in the cytoplasmic (55 kDa) and nuclear (60
and 70 kDa) fractions (Fig. 2A). The p220CHNesp2 variant was also
detected in both nuclear and cytoplasmic fractions in VSMCs
(Fig. 2B), however, the p380CHNesp2 variant was nuclear in HDF
cells (Fig. 2C). In all cell types tested, unknown variants were de-
tected, suggesting that our knowledge of nesprin-2 variants re-
mains incomplete (Fig. 2A–C).
3.2. Nesprin-2 variants localise to cell-cell junctions and interact
with β-catenin
Next, we employed confocal ﬂuorescence microscopy (IF) to
investigate the cellular localisations of these variants. IF demon-
strated that the nesprin-2 antibody raised to the N-terminus of
nesprin-2 giant (N2CH3) diffusely stained within the nucleus and
at the sites of cell-cell contact at the cell periphery, where nesprin-
2 colocalised with active β-catenin in U2OS cells (Fig. 3A and B). InB.A.
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Fig. 2. N-terminal nesprin-2 variants reside in the cytoplasm and nucleus. WB of U2
polyacrylamide gels. * mark unidentiﬁed nesprin variant bands.contrast, no colocalisation with β-catenin was observed in HDF
cells (Supplementary Fig. 2). To investigate the signiﬁcance of
nesprin-2 localisation at cell-cell contacts further, U2OS cells were
grown in high or low calcium conditions to promote or inhibit
cadherin mediated cell junction formation respectively. IF revealed
that, U2OS cells in the presence of high calcium, displayed colo-
calisation of nesprin-2 and active β-catenin at cell-cell junctions,
however, localisation of both nesprin-2 and β-catenin is rapidly
lost from the plasma membrane when cells were switched to low
calcium conditions to promote cadherin disassembly (Fig. 3B).
Localisation of nesprin-2 and β-catenin at cell-cell contacts was
rescued by replenishing calcium levels (Fig. 3B).
To further interrogate the localisation of nesprin-2 variants that
retain the CHD but lack the KASH domain, we employed an
overexpression strategy using an N-terminal nesprin-2 construct
that possessed the CHD and the antibody binding region (amino
acids 1-531) (Fig. 3A). IF demonstrated that the N-terminal frag-
ment (GFP-ABDN2) colocalised efﬁciently with active β-catenin at
cell-cell junctions in U2OS (Fig. 3C, left panel) and HDFs (Fig. 3C,
right panel). Importantly a similar fragment of nesprin-1 failed to
localise to cell-cell junctions and was predominantly nuclear,
suggesting that cell-cell junction localisation is speciﬁc for ne-
sprin-2 (Supplementary Fig. 3). To further deﬁne the requirements
for cell-cell junction localisation, we next expressed the CHD re-
gion (amino acids 1-279) of nesprin-2. IF revealed that the CHD
localised to cell-cell junctions, although some stress ﬁbre staining
was also observed (Fig. 3C).
Next, we investigated whether nesprin-2 interacted with β-ca-
tenin by performing immunoprecipitation experiments. WB re-
vealed that β-catenin was precipitated by the GFP-ABDN2 fragment
but not GFP-alone (Fig. 4A and B). Conversely, the GFP-ABDN2
fragment was efﬁciently precipitated by β-catenin IP, conﬁrming
the nesprin-2 is a novel β-catenin interacting protein (Fig. 4C). Next,
we mapped the β-catenin binding site by fusing the SR region of the
ABDN2 construct (SR 1-3 containing amino acids 278-531) to GST
(Fig. 4A). GST pull down assays conﬁrmed that β-catenin was pre-
cipitated by GST-SR 1-3, but not GST alone (Fig. 4D), conﬁrming that
this spectrin repeat region interacts with β-catenin.
3.3. Nesprin-2 disruption induces cell-cell junction disassembly and
augments β-catenin transcriptional activity
We next investigated the impact of nesprin-2 disruption on β-
catenin localisation by utilising a siRNA mediated knockdownC.
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U2OS cells were transfected with either control or nesprin-2
speciﬁc siRNA that targeted the N-terminus of p220CHNeps2 and
p380CHNesp2 (Fig. 5A). WB analysis conﬁrmed knockdown of
p220CHNesp2 using 3 independent nesprin-2 speciﬁc siRNAs
(Fig. 5B and C). Levels of the p380CHNesp2 variant remainedunaltered by our siRNA strategy (Fig. 5B and D), suggesting that
p380CHNesp2 is more stable than p220CHNesp2. WB also revealed
that protein levels of C-terminal variants that lack the siRNA target
sequence remain unaltered (Fig. 5B). Importantly, levels of active
β-catenin and total β-catenin remained unaltered by our nesprin-2
depletion strategy (Fig. 5B). To speciﬁcally target the p220CHNesp2
B. C.
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ique 3′UTRs, however, WB revealed that this strategy was un-
successful and failed to deplete the p220CHNesp2 and p380CHNesp2
variants (Supplementary Fig. 4).
IF was performed to observe whether nesprin-2 depletion al-
tered β-catenin organisation in U2OS cells and revealed that ne-
sprin-2 depleted cells displayed reduced staining of active β-ca-
tenin at cell-cell junctions compared to control cells (Fig. 6A and B
and Supplementary Fig. 5A), suggesting that the p220CHNesp2
variant tethers active β-catenin to the sites of cell-cell contact.
Importantly, subcellular fractionation revealed that nesprin-2 de-
pleted cells displayed increased levels of nuclear active β-catenin
(Fig. 6C) and TOP-FLASH/FOP-FLASH luciferase assays conﬁrmed
that nesprin-2 depleted cells possessed augmented β-catenin
transcriptional activity compared to control cells (Fig. 6D). In
contrast, siRNAs targeting the C-terminus of nesprin-2 giant that
the p380CHNesp2 and p220CHNesp2 variants lack, failed to alter
luciferase activity (Fig. 6A and D), supporting the notion thatN-terminal variants are responsible for localising β-catenin to cell-
cell junctions. Next, we assessed the impact of overexpression of
the β-catenin binding fragments of the N-terminal nesprin-2
variants on β-catenin signalling. However, TOP-FLASH/FOP-FLASH
luciferase assays revealed that the β-catenin binding fragments
had no impact on β-catenin transcriptional activity (Supplemen-
tary Fig. 5B).
3.4. β-catenin localisation at cell-cell junctions is independent of
emerin
Previous studies have shown that nesprin disruption triggers
nuclear morphology defects, so we next performed IF to observe if
our siRNA strategy altered nuclear morphology. Analysis revealed
that control cells contained spherical nuclei, however, nesprin-2
depleted nuclei possessed a more convoluted morphology (Fig. 7A
and B). Next, we performed IF to observe the localisation of the
nesprin-2 interacting protein emerin and show that nesprin-2
A.
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WB of N-terminal (N2CH3) and C-terminal (N2N3) variants after control and nesprin-2 (siN2CH2/CH3/CH4) siRNA knockdown. Samples were separated on 8% poly-
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emerin has previously been implicated in β-catenin signalling, we
further investigated whether changes in β-catenin signalling were
due to impaired emerin function by performing emerin knock-
down experiments. WB conﬁrmed efﬁcient emerin depletion in
U2OS cells (Fig. 8A), however, β-catenin organisation and tran-
scriptional activity remained unaltered in emerin depleted cells
(Fig. 8B and C).4. Discussion
Nesprins have emerged as signalling scaffold proteins that lo-
calise to multiple subcellular compartments, including the NE,cytoplasm and nucleoplasm [5,6]. In this current study, we show
that nesprin-2 N-terminal variants colocalise with β-catenin at
cell-cell junctions. We show that a fragment containing the CHD
and SR 1-3 region (ABDN2) was sufﬁcient for both β-catenin
binding and cell-cell junction localisation. Further mapping iden-
tiﬁed the N-terminal SRs 1-3 of nesprin-2 as a novel β-catenin
binding region, although we did not rule out the possibility that
the CHD and β-catenin also interact. We propose that the
N-terminal nesprin-2 KASH-less variants tether β-catenin at cell-
cell junctions and inhibit β-catenin transcriptional activity. In
support of this notion, nesprin-2 depleted U2OS cells displayed
loss of β-catenin from cell-cell contacts, accumulation of active β-
catenin in the nucleus and augmented β-catenin transcriptional
activity. Importantly, levels of active β-catenin remained
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Fig. 6. Nesprin-2 is required for β-catenin localisation at cell-cell junctions and negatively regulates β-catenin transcriptional activity. A) Schematic representation of
siN2CH2/siN2CH5 and siN2KASH target regions. B) IF of active β-catenin (Aβ-catenin) (green), F-actin (red) and DAPI (blue) in control and nesprin-2 (siN2CH2) depleted
U2OS cells. Scale bar¼25 mm. C) WB of control, siN2CH2 and siN2CH5 cytoplasmic (C) and nuclear (N) fractions. D) TOP/FOP Luciferase assay of control, siN2CH2, siN2CH5
and siN2KASH depleted cells. Graph shows combined data from 3 independent experiments repeated in triplicate (*p¼o0.05, **po0.001).
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Fig. 7. Nesprin-2 disruption alters nuclear morphology but not emerin localisation. A) IF of nesprin-2 (green), emerin (red), and DAPI (blue) staining of control and nesprin-2
depleted cells. Scale bar¼10 mm. B) Quantiﬁcation of number of control and nesprin-2 depleted (siN2CH2 and siN2CH5) cells displaying convoluted nuclei. Graph show
combined data from 3 independent experiments counting 300 cells per group (**p¼o0.001 and ***p¼o0.0001). C) IF staining of DAPI (blue), N2CH3 (green) and emerin
(red) in control and nesprin-2 depleted U2OS cells. Scale bar¼25 mm.
Q. Zhang et al. / Experimental Cell Research 345 (2016) 168–179176unchanged in nesprin-2 depleted U2OS cells, suggesting that ne-
sprin-2 depletion triggers redistribution of active β-catenin from
cell-cell contacts to the nucleus. Our overexpression experiments
show that N-terminal CHD containing nesprin-2 fragments loca-
lise to cell-cell contacts, colocalise with active β-catenin but did
not alter β-catenin transcriptional activity. N-terminal nesprin-2
fragments that lack the CHD but retain the β-catenin binding sitealso failed to alter β-catenin transcriptional activity. This suggests
that the association between active β-catenin and the N-terminal
nesprin-2 variants at cell-cell contacts is stable, further experi-
mentation is required to elucidate the functions/dynamics of these
N-terminal nesprin-2 variants at cell-cell contacts.
We also demonstrate that the p220CHNesp2 and p380CHNesp2
variants, that contain the β-catenin binding domain, reside in both
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Fig. 8. Emerin disruption does not impact on β-catenin localisation. A) WB conﬁrming emerin knockdown. B) IF of active β-catenin (Aβ-catenin) (green), F-actin (red) and
DAPI (blue) in control and emerin depleted U2OS cells. Scale bar¼25 mm. C) TOP/FOP luciferase assay of control and emerin depleted cells. Graph shows combined data from
3 independent experiments repeated in triplicate.
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these KASH-less variants may shuttle between these compart-
ments. However, further investigation is now required to clarify
whether KASH-less nesprin-2 variants associate with and organise
other components of the β-catenin pathway, as well as to identify
the exact nesprin-2 variant. Our knockdown strategy efﬁciently
depleted p220CHNesp2 but not p380CHNesp2 and presumably these
two variants display differences in protein turnover as both con-
tain the target sequence. This suggests that p220CHNesp2 is po-
tentially a good candidate for future investigation however, our
siRNA strategy targeted multiple nesprin-2 variants so the possi-
bility remains that an unidentiﬁed variant may localise to cell-cell
contacts and regulate β-catenin signalling.
4.1. N-terminal nesprin-2 variants regulate β-catenin signalling in-
dependently of the NE
Nesprin-2 variants organise the NE and several recent studies
have identiﬁed the NE as a novel regulator of β-catenin signalling
[22,23,30]. Firstly, β-catenin interacts with the C-terminus of the
nesprin-2 giant to positively regulate β-catenin signalling [22]. In
addition, the nesprin-1/2 orthologue ANC1 regulates β-catenin
signalling during neuronal development in Caenorhabditis elegans
[30]. Due to the sequence identity between nesprin-2 variants, our
knockdown strategy potentially targeted both KASH-less N-term-
inal and the KASH-containing nesprin-2 giant variants [5]. Im-
portantly, we show that U2OS cells lack nesprin-2 giant and β-catenin transcriptional activity was enhanced by N-terminal ne-
sprin-2 depletion in U2OS cells. These data suggest that the
N-terminal nesprin-2 variants negatively regulate β-catenin tran-
scriptional activity in U2OS cells and highlight the complexity of
nesprin-2 function in regulating β-catenin signalling. Previous
studies have also demonstrated that emerin interacts with both
the C-terminal nesprin-2 variants and β-catenin at the INM to
negatively regulate β-catenin mediated transcription [23]. KASH-
containing nesprin-2 variants are essential for emerin organisation
at the NE [6], however, emerin organisation was unaltered by
depletion of N-terminal nesprin-2 variants in U2OS cells, sug-
gesting that changes in β-catenin signalling induced by our siRNA
strategy were NE independent. Furthermore, emerin depletion in
U2OS cells failed to displace β-catenin from cell-cell junctions or
alter β-catenin transcriptional activity, further suggesting that the
N-terminal nesprin-2 variants regulate β-catenin signalling in-
dependently of the NE.
Despite our evidence showing that nuclear envelope function
is not disrupted by our nesprin-2 siRNA strategy, nuclear mor-
phology was altered by our approach. Previous studies have de-
monstrated that actomyosin, cell morphology and adhesion all
contribute to deﬁning nuclear morphology and potentially, in
addition to disrupting cell-cell contacts, our nesprin-2 depletion
strategy induced cytoskeletal reorganisation that altered nuclear
morphology [27,28]. However, the potential role of the nesprin-2
N-terminal variants in cytoskeletal organisation remains
untested.
Q. Zhang et al. / Experimental Cell Research 345 (2016) 168–1791784.2. Nesprin-2 variants ﬁne tune β-catenin signalling for cell speciﬁc
functions?
Nesprin variants demonstrate complex tissue and cell-speciﬁc
distributions [5,29]. Nesprin giant variant expression is abundant
in the majority of human tissues, except cardiac and skeletal
muscle, which are enriched in shorter isoforms [29]. In addition,
the nesprin-2 epsilon-1 and epsilon-2 variants are highly ex-
pressed in embryonic stem cells (ESC) and heart respectively [29].
Here, we conﬁrm that the p220CHNesp2 and p380CHNesp2 variants
display cell-speciﬁc expression, suggesting that nesprin function is
tailored to speciﬁc cellular functions. In support of this, up reg-
ulation of nesprin variants and nesprin variant switching is ob-
served in ESC, mesenchymal stem cell and skeletal muscle differ-
entiation [26,30,31]. Nesprins have emerged as signalling scaffolds
for the ERK and β-catenin pathways and these pathways exist in
multiple cell types. Furthermore, recent evidence demonstrates
the importance of the signalling scaffolding functions of the ne-
sprin family during development, where the nesprin-1/2 ortho-
logue ANC1 regulates β-catenin signalling during neuronal de-
velopment in C. elegans [32]. However, we show that the nesprin-2
giant is not detectable in U2OS cells and potentially adaptation of
nesprin variant expression may ﬁne tune these pathways and fa-
cilitate cell-speciﬁc signalling. In support of this, we show that
U2OS cells display high levels of the p220CHNesp2, whereas ﬁbro-
blasts lack the p220CHNesp2 variant. In addition to changes in ne-
sprin-2 variant expression, the p380CHNesp2 variant displayed
differential compartmentalisation between U2OS and HDF cells,
therefore, differential nesprin variant expression/compartmenta-
lisation may contribute to cell speciﬁc functions for nesprin-2 in β-
catenin signalling. Further investigation is now required to clarify
the cell-speciﬁc functions of nesprin variants in regulating β-ca-
tenin signalling.Conﬂicts of interest
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